CytoDyn Announces First Patient Dosed in Expanded Access Program for Leronlimab in Triple-Negative Breast Cancer

FREE Breaking News Alerts from StreetInsider.com!

E-mail Address

StreetInsider.com Top Tickers, 6/23/2026

1. PRIM
2. ABBV
3. IBM
4. META
5. DPZ
6. DFTX
7. CNC
8. KFY
9. SPY
10. MU

Go back to CytoDyn Announces First Patient Dosed in Expanded Access Program for Leronlimab in Triple-Negative Breast Cancer
CytoDyn, Inc. (AMEX: CYDY) Delayed: 0.26 --0 (-0%)
Previous Close $0.26    52 Week High $1.57 
Open $0.26    52 Week Low $0.61 
Day High $0.26    P/E N/A 
Day Low $0.26    EPS $0.00 
Volume 1,777